Ai Jiaoyu, He Wenhua, Huang Xin, Wu Yao, Lei Yupeng, Yu Chen, Görgülü Kivanc, Diakopoulos Kalliope N, Lu Nonghua, Zhu Yin
The Department of Gastroenterology.
The Department of Radiology, The First Affiliated Hospital of Nanchang University, Jiangxi, China.
Medicine (Baltimore). 2020 Oct 16;99(42):e22644. doi: 10.1097/MD.0000000000022644.
Glycogen storage disease type IA (GSD IA) is an inherited disorder of glycogen metabolism characterized by fasting hypoglycemia, hyperuricemia, and hyperlipidemia including hypertriglyceridemia (HTG). Patients have a higher risk of developing acute pancreatitis (AP) because of HTG. AP is a potentially life-threatening disease with a wide spectrum severity. Nevertheless, almost no reports exist on GSD IA-induced AP in adult patients.
A 23-year-old male patient with GSD 1A is presented, who developed moderate severe AP due to HTG.
The GSD 1A genetic background of this patient was confirmed by Sanger sequencing. Laboratory tests, along with abdominal enhanced-computed tomography, were used for the diagnosis of HTG and AP.
This patient was transferred to the intensive care unit and treated by reducing HTG, suppressing gastric acid, inhibiting trypsin activity, and relieving hyperuricemia and gout.
Fifteen days after hospital admission, the patient had no complaints about abdominal pain and distention. Follow-up of laboratory tests displayed almost normal values. Reexamination by computed tomography exhibited a reduction in peripancreatic necrotic fluid collection compared with the initial stage.
Fast and long-term reduction of triglycerides along with management of AP proved effective in relieving suffering of an adult GSD IA-patient and improving prognosis. Thus, therapeutic approaches have to be renewed and standardized to cope with all complications, especially AP, and enable a better outcome so that patients can master the disease.
糖原贮积病IA型(GSD IA)是一种糖原代谢的遗传性疾病,其特征为空腹低血糖、高尿酸血症以及包括高甘油三酯血症(HTG)在内的高脂血症。由于HTG,患者发生急性胰腺炎(AP)的风险更高。AP是一种潜在的危及生命的疾病,严重程度范围广泛。然而,几乎没有关于成年患者GSD IA诱发AP的报道。
本文介绍了一名23岁患有GSD 1A的男性患者,他因HTG发展为中度重症AP。
通过桑格测序确认了该患者的GSD 1A基因背景。实验室检查以及腹部增强计算机断层扫描用于诊断HTG和AP。
该患者被转入重症监护病房,并通过降低HTG、抑制胃酸、抑制胰蛋白酶活性以及缓解高尿酸血症和痛风进行治疗。
入院15天后,患者无腹痛和腹胀主诉。实验室检查随访显示几乎所有值均正常。计算机断层扫描复查显示,与初始阶段相比,胰周坏死液体积聚减少。
快速且长期降低甘油三酯以及对AP的管理被证明对缓解成年GSD IA患者的痛苦和改善预后有效。因此,必须更新和规范治疗方法,以应对所有并发症,尤其是AP,并实现更好的结果,使患者能够控制疾病。